India Receives Offer For Russian Vaccine Trial, Manufacture: Official

12Shares

In this photo provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Russia on Aug. 6, 2020.(Photo | AP)

Bengaluru: India has received an offer from Russia to conduct a trial and manufacture its “Sputnik-V” COVID-19 vaccine, with several Indian companies currently studying the proposal, a government official said on Tuesday.

“The government of India attaches great importance to this offer of partnership from a friend,” said V. K. Paul, NITI Aayog member.

The outcome of discussions on the offer were expected soon, he added.

Be Part of Quality Journalism

Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.

ACT NOW
MONTHLYRs 100
YEARLYRs 1000
LIFETIMERs 10000

CLICK FOR DETAILS


Agencies

Leave a Reply

Your email address will not be published.

KO SUPPLEMENTS